Infection, Immunosuppression and Treatment of Auto-Immune Inflammatory Kidney Disease

Detalhes bibliográficos
Autor(a) principal: Póvoas, D
Data de Publicação: 2021
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.17/3911
Resumo: Immunosuppressive drugs are the cornerstone of treatment of auto-immune inflammatory diseases (AIIDs) with renal involvement. However, the most commonly used drugs in this setting can increase the risk of bacterial, fungal, and viral infection, and also impair immune response following vaccination. Recommendations and evidence on strategies for infection prevention in the setting of AIIDs treatment will be reviewed.
id RCAP_9a426c078051541f1a9c337f5df6a06a
oai_identifier_str oai:repositorio.chlc.min-saude.pt:10400.17/3911
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Infection, Immunosuppression and Treatment of Auto-Immune Inflammatory Kidney DiseaseHCC INFImmunosuppressionInfectionPreventionImmunosuppressive drugs are the cornerstone of treatment of auto-immune inflammatory diseases (AIIDs) with renal involvement. However, the most commonly used drugs in this setting can increase the risk of bacterial, fungal, and viral infection, and also impair immune response following vaccination. Recommendations and evidence on strategies for infection prevention in the setting of AIIDs treatment will be reviewed.Sociedade Portuguesa de Nefrologia e HipertensãoRepositório do Centro Hospitalar Universitário de Lisboa Central, EPEPóvoas, D2021-11-19T16:20:11Z20212021-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/3911engPort J Nephrol Hypert 2021; 35(3): 170-17810.32932/pjnh.2021.10.143info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-10T09:44:36Zoai:repositorio.chlc.min-saude.pt:10400.17/3911Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:21:13.312965Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Infection, Immunosuppression and Treatment of Auto-Immune Inflammatory Kidney Disease
title Infection, Immunosuppression and Treatment of Auto-Immune Inflammatory Kidney Disease
spellingShingle Infection, Immunosuppression and Treatment of Auto-Immune Inflammatory Kidney Disease
Póvoas, D
HCC INF
Immunosuppression
Infection
Prevention
title_short Infection, Immunosuppression and Treatment of Auto-Immune Inflammatory Kidney Disease
title_full Infection, Immunosuppression and Treatment of Auto-Immune Inflammatory Kidney Disease
title_fullStr Infection, Immunosuppression and Treatment of Auto-Immune Inflammatory Kidney Disease
title_full_unstemmed Infection, Immunosuppression and Treatment of Auto-Immune Inflammatory Kidney Disease
title_sort Infection, Immunosuppression and Treatment of Auto-Immune Inflammatory Kidney Disease
author Póvoas, D
author_facet Póvoas, D
author_role author
dc.contributor.none.fl_str_mv Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE
dc.contributor.author.fl_str_mv Póvoas, D
dc.subject.por.fl_str_mv HCC INF
Immunosuppression
Infection
Prevention
topic HCC INF
Immunosuppression
Infection
Prevention
description Immunosuppressive drugs are the cornerstone of treatment of auto-immune inflammatory diseases (AIIDs) with renal involvement. However, the most commonly used drugs in this setting can increase the risk of bacterial, fungal, and viral infection, and also impair immune response following vaccination. Recommendations and evidence on strategies for infection prevention in the setting of AIIDs treatment will be reviewed.
publishDate 2021
dc.date.none.fl_str_mv 2021-11-19T16:20:11Z
2021
2021-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.17/3911
url http://hdl.handle.net/10400.17/3911
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Port J Nephrol Hypert 2021; 35(3): 170-178
10.32932/pjnh.2021.10.143
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Nefrologia e Hipertensão
publisher.none.fl_str_mv Sociedade Portuguesa de Nefrologia e Hipertensão
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131308403720192

Registros relacionados